Navigation Links
Chinese Colorectal Cancer Drug Market Will More Than Double by 2012
Date:4/13/2009

Modest Increase in Market Share Expected for Western Drug Companies, According to a Report from Decision Resources

WALTHAM, Mass., April 13 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that the colorectal cancer drug market in China will more than double by 2012, growing from $118 million in 2007 to $290 million in 2012. This growth will be fueled by a large increase in colorectal cancer incident cases, improvement in access to medical care and significantly increased prescribing of targeted therapies.

"The increased use of Merck KGaA's Erbitux and Jiangsu Simcere's Endostar and the launch of Roche's Avastin will be the strongest drivers of the Chinese colorectal drug market during the next five years," stated Jing Wu, M.S., MBA. "We also expect a high uptake of Roche's Xeloda -- an oral pro-drug of 5-fluorouracil (5-FU) -- due to its delivery advantage over intravenous 5-FU and its inclusion on the National Reimbursement Drug List."

The new Emerging Markets report entitled Colorectal Cancer in China also finds that modest increase in market share is expected for Western drug companies by 2012. This growth will result from the increased uptake of Western-branded, targeted agents and the decreasing market share of conventional chemotherapy drugs owing to fierce competition from domestic products. The report contains primary research of physicians and epidemiology study in key pharmaceutical markets of China -- Beijing, Shanghai, Guangzhou -- and in the high-growth second-tier markets of Tianjin, Wuhan, Nanjing, Hangzhou and Jinan.

About Emerging Markets Reports

Decision Resources is the FIRST and ONLY company to offer a syndicated report series for high-growth emerging markets with comprehensive disease-specific analysis. Each report assesses the commercial opportunity in the pharmaceutical market for a disease based on population demographics, economic development, disease epidemiology and changing physicians' practices.

About Decision Resources

Decision Resources (www.DecisionResources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

    Natalia Morales                              Elizabeth Marshall
    Decision Resources                           Decision Resources, Inc.
    781-296-2691                                 781-296-2563
    nmorales@dresources.com                      emarshall@dresources.com


'/>"/>
SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Americas Watchdog Calls On President Obama To Get Involved With The Toxic Chinese Drywall Disaster--Now
2. Samplify Expands Global Distribution Channel; Signs Top-Ranked Chinese Distributor, Excelpoint
3. Class Action Filed Against South Florida Developer and Supplier of Defective Chinese Drywall
4. Traditional Chinese Therapy May Help Ease Eczema
5. Defective Chinese Drywall Lawsuit: Florida Homeowners' Associations and Condominium Associations Plagued by Defective Chinese Drywall Urged to Investigate their Rights
6. HUYA Bioscience International Announces Collaboration Agreement With the Beijing Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College
7. Elder Abuse Prevention the Focus of Wayne County Medical Society Foundations Annual Chinese New Year Fundraiser
8. Genesis Pharmaceuticals Enters Into Agreement to Purchase Hongrui Pharmaceuticals, and Acquire 22 New Traditional Chinese Medicines
9. Chinese Dental Implant Market Promises Strong Growth
10. The Khanna Institute of Lasik Surgery Offers Better Vision for the Chinese New Year
11. M. D. Andersons Cohen honored for contributions to traditional Chinese medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... ... May 02, 2016 , ... Dr. Rassouli, dentist in Orange ... decline. According to the research, which was published in the “Journal of the American ... and about 5.4 million Americans have Alzheimer’s disease. The study found that dental problems ...
(Date:5/2/2016)... ... May 02, 2016 , ... According to an ... in four girls are sexually abused before the age of 18. Of those who ... tell her story and others. , In her new book, Lyah! Lyah! Pants ...
(Date:5/2/2016)... ... 02, 2016 , ... A research team, including a director ... determined that the adjustability and adaptability of pediatric support surfaces – characteristics of ... which are now referred to as “pressure injuries” by the National Pressure Ulcer ...
(Date:5/2/2016)... ... May 02, 2016 , ... MedaCheck, a leading ... quality outcomes, has announced its partnership with GrandView Health Services. , With decades ... the counter and prescription drug pharmacy services to thousands of residents. Serving Indiana, ...
(Date:5/2/2016)... ... ... One of Hollywood’s best kept secrets for non-invasive fat reduction, CoolSculpting , ... “Patients with busy lives want noninvasive options for fat removal, where they can come ... work without having to wear recovery garments or take time off work or activity,” ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)...  While Abbott,s announced purchase of St. Jude ... and stent business, healthcare research firm Kalorama Information ... into patient monitoring.  Kalorama said that patient monitoring ... with double-digit growth expected the next 5 years, ... Patient Monitoring . Abbott Laboratories agreed to ...
(Date:4/28/2016)... NEW YORK , April 28, 2016  The ... reached 275 million dollars, according to Kalorama Information and ... includes typing, immunoassays and nucleic acid testing.  The healthcare ... had made progress in developing blood collection stations and ... was made in Kalorama Information,s report, Blood ...
(Date:4/28/2016)... April 28, 2016 Oramed Pharmaceuticals Inc. ... pharmaceutical company focused on the development of oral drug delivery ... upcoming PIONEERS 2016 conference, presented by Joseph Gunnar ... New York . Nadav Kidron , ... conference. Presentation Details:   PIONEERS ...
Breaking Medicine Technology: